For comments, suggestions
Created with Raphaël 2.1.0 17.10.2016 Filing date 24.04.2018 Validation fee payment 31.10.2018 (A1) Patent application published 22.06.2021 AGEPI application filing date 30.09.2021 (T2) Translation of the validated European patent 15.05.2025 17.10.2025 Valid until 18.10.2026 Renewal fee to be paid until 17.10.2036 Patent will expire on

Patent in force


(210)Number of the EPO application16781816
(220)Filing date of the EPO application2016.10.17
(80)EPO patent specification publication (B)EPB nr. 14/2021, 2021.04.07
(110)EPO patent number3364975
(11)Number of the documentMD 3364975 T2
(21)Number of the applicatione 2018 0825
(71)Name(s) of applicant(s), code of the countryAZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A., IT;
(72)Name(s) of inventor(s), code of the countryGARRONE Beatrice, IT;
DURANDO Lucia, IT;
CALISTI Fabrizio, IT;
(73)Name(s) of owner(s), code of the countryAZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A., IT;
(54)Title of the inventionCombination of trazodone and gabapentin for the treatment of pain
(13)Kind-of-document code T2
(51)International Patent Classification A61K 31/496 (2006.01.01); A61P 25/02 (2006.01.01); A61P 25/04 (2006.01.01); A61K 45/06 (2006.01.01); A61K 31/195 (2006.01.01); A61P 25/00 (2006.01.01)
(19)CountryIT
(41)Date of publication of the application2018.10.31
(49)Date of publication of the translation of the validated European patent specification2021.09.30
(30)Priority15191024, 2015.10.22, EP
(74)Patent attorney(Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova
(86)International applicationPCT/EP2016/074835, 2016.10.17
(87)International publicationWO 2017/067870, 2017.04.27
Up
/Inventions/details/3364975